These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 35024828)

  • 1. Biological Variation of Donor-Derived Cell-Free DNA in Stable Lung Transplant Recipients.
    Keller M; Mutebi C; Shah P; Levine D; Aryal S; Iacono A; Timofte I; Mathew J; Varghese A; Giner C; Agbor-Enoh S
    J Appl Lab Med; 2022 Jun; 7(4):901-909. PubMed ID: 35024828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological Variation of Donor-Derived Cell-Free DNA in Renal Transplant Recipients: Clinical Implications.
    Bromberg JS; Brennan DC; Poggio E; Bunnapradist S; Langone A; Sood P; Matas AJ; Mannon RB; Mehta S; Sharfuddin A; Fischbach B; Narayanan M; Jordan SC; Cohen DJ; Zaky ZS; Hiller D; Woodward RN; Grskovic M; Sninsky JJ; Yee JP; Bloom RD
    J Appl Lab Med; 2017 Nov; 2(3):309-321. PubMed ID: 33636851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Utility of Donor-Derived Cell-Free DNA in Heart Transplant Recipients With Multi-Organ Transplants.
    Moeller CM; Oren D; Fernandez Valledor A; Rubinstein G; Lotan D; Mehlman Y; Slomovich S; Rahman S; Lee C; Baranowska J; Regan M; Elad B; DeFilippis EM; Hennecken C; Salazar R; Raikhelkar J; Clerkin KJ; Fried J; Lin E; Bae D; Oh KT; Latif F; Topkara VK; Naka Y; Takeda K; Majure D; Uriel N; Sayer G
    Clin Transplant; 2024 Oct; 38(10):e15479. PubMed ID: 39422086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor-derived cell-free DNA as a composite marker of acute lung allograft dysfunction in clinical care.
    Keller M; Sun J; Mutebi C; Shah P; Levine D; Aryal S; Iacono A; Timofte I; Mathew J; Varghese A; Giner C; Agbor-Enoh S
    J Heart Lung Transplant; 2022 Apr; 41(4):458-466. PubMed ID: 35063338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: A prospective multicenter study.
    Khush KK; Patel J; Pinney S; Kao A; Alharethi R; DePasquale E; Ewald G; Berman P; Kanwar M; Hiller D; Yee JP; Woodward RN; Hall S; Kobashigawa J
    Am J Transplant; 2019 Oct; 19(10):2889-2899. PubMed ID: 30835940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of plasma donor-derived cell free DNA for lung allograft rejection diagnosis in lung transplant recipients.
    Ju C; Xu X; Zhang J; Chen A; Lian Q; Liu F; Liu H; Cai Y; Zou Y; Yang Y; Zhou Y; He J
    BMC Pulm Med; 2023 Jan; 23(1):37. PubMed ID: 36703125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a donor-derived cell-free DNA assay to monitor treatment response in pediatric renal transplant recipients with allograft rejection.
    Steggerda JA; Pizzo H; Garrison J; Zhang X; Haas M; Kim IK; Jordan SC; Puliyanda DP
    Pediatr Transplant; 2022 Jun; 26(4):e14258. PubMed ID: 35340104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of donor-derived cell-free DNA between single versus double lung transplant recipients.
    Keller MB; Meda R; Fu S; Yu K; Jang MK; Charya A; Berry GJ; Marboe CC; Kong H; Luikart H; Ponor IL; Shah PD; Khush KK; Nathan SD; Agbor-Enoh S
    Am J Transplant; 2022 Oct; 22(10):2451-2457. PubMed ID: 35322546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical Validation of a Single-nucleotide Polymorphism-based Donor-derived Cell-free DNA Assay for Detecting Rejection in Kidney Transplant Patients.
    Altuğ Y; Liang N; Ram R; Ravi H; Ahmed E; Brevnov M; Swenerton RK; Zimmermann B; Malhotra M; Demko ZP; Billings PR; Ryan A
    Transplantation; 2019 Dec; 103(12):2657-2665. PubMed ID: 30801536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-centre analytical performance verification of an IVD assay to quantify donor-derived cell-free DNA in solid organ transplant recipients.
    Casas S; Tangprasertchai NS; Oikonomaki K; Mathers S; Sollet ZC; Samara S; Liu J; Burlinson ND; Constantoulakis P; Villard J; Viard T
    HLA; 2024 May; 103(5):e15518. PubMed ID: 38733247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor-derived cell-free DNA is associated with cardiac allograft vasculopathy.
    Holzhauser L; Clerkin KJ; Fujino T; Alenghat FJ; Raikhelkar J; Kim G; Sayer G; Uriel N
    Clin Transplant; 2021 Mar; 35(3):e14206. PubMed ID: 33368611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol-based donor-derived cell-free DNA surveillance in kidney transplant recipients: A single-center experience.
    Nissaisorakarn P; Patel H; Amtul A; Pavlakis M
    Clin Nephrol; 2022 Aug; 98(2):65-74. PubMed ID: 35445660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-free DNA in lung transplantation: research tool or clinical workhorse?
    Keller M; Agbor-Enoh S
    Curr Opin Organ Transplant; 2022 Jun; 27(3):177-183. PubMed ID: 35649108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Assessment of the Value of Donor-derived Cell-free DNA Surveillance in Patients With Preserved Kidney Allograft Function.
    Huang E; Haas M; Gillespie M; Sethi S; Peng A; Najjar R; Vo A; Jordan SC
    Transplantation; 2023 Jan; 107(1):274-282. PubMed ID: 35913057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in Noninvasive Surveillance for Acute Rejection in Pediatric Heart Transplant Recipients: A Real-World Analysis of Donor-Derived Cell-Free DNA-Based Surveillance Protocol.
    Akabas L; Bravo SA; Zhang Y; Simonelli A; Zuckerman WA; Richmond ME; Lytrivi ID
    Clin Transplant; 2024 Oct; 38(10):e15481. PubMed ID: 39412485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of donor-derived Cell-Free DNA in pediatric kidney transplant recipients: A single center study.
    Ranch D; Fei M; Kincade E; Piburn K; Hitchman K; Klein K
    Pediatr Transplant; 2024 Feb; 28(1):e14582. PubMed ID: 37550268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-Derived Cell-Free DNA (dd-cfDNA) in Kidney Transplant Recipients With Indication Biopsy-Results of a Prospective Single-Center Trial.
    Benning L; Morath C; Fink A; Rudek M; Speer C; Kälble F; Nusshag C; Beimler J; Schwab C; Waldherr R; Zeier M; Süsal C; Tran TH
    Transpl Int; 2023; 36():11899. PubMed ID: 38020751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a Clinical-Grade Assay to Measure Donor-Derived Cell-Free DNA in Solid Organ Transplant Recipients.
    Grskovic M; Hiller DJ; Eubank LA; Sninsky JJ; Christopherson C; Collins JP; Thompson K; Song M; Wang YS; Ross D; Nelles MJ; Yee JP; Wilber JC; Crespo-Leiro MG; Scott SL; Woodward RN
    J Mol Diagn; 2016 Nov; 18(6):890-902. PubMed ID: 27727019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extreme elevations of donor-derived cell-free DNA increases the risk of chronic lung allograft dysfunction and death, even without clinical manifestations of disease.
    Keller MB; Newman D; Alnababteh M; Ponor L; Shah P; Mathew J; Kong H; Andargie T; Park W; Charya A; Luikart H; Aryal S; Nathan SD; Orens JB; Khush KK; Jang M; Agbor-Enoh S
    J Heart Lung Transplant; 2024 Sep; 43(9):1374-1382. PubMed ID: 38705500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining donor-derived cell-free DNA and donor specific antibody testing as non-invasive biomarkers for rejection in kidney transplantation.
    Obrișcă B; Butiu M; Sibulesky L; Bakthavatsalam R; Smith KD; Gimferrer I; Warner P; Ismail G; Leca N
    Sci Rep; 2022 Sep; 12(1):15061. PubMed ID: 36064740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.